Company mission:

Cure Lab is a biotechnology company committed to the development of effective vaccines against infectious diseases and cancer.

      
DNA Company focus:

Cure Lab is intensively focusing on development of vaccines against influenza due to the threat of an impending pandemic.

The first in the pipeline of Cure Lab's anti-influenza T-cell vaccines (CLVax 1.0) has demonstrated protection against a wide variety of both mammalian and avian influenza (flu) strains when tested in rodent and chicken models.

Cure Lab, Inc. is a private biotechnology company founded in 2002.